Groupe la Francaise Acquires Shares of 127,200 Simulations Plus, Inc. $SLP

by · The Cerbat Gem

Groupe la Francaise acquired a new stake in shares of Simulations Plus, Inc. (NASDAQ:SLP – Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 127,200 shares of the technology company’s stock, valued at approximately $2,329,000. Groupe la Francaise owned approximately 0.63% of Simulations Plus as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Raymond James Financial Inc. bought a new position in Simulations Plus during the second quarter valued at approximately $25,000. Quarry LP purchased a new position in Simulations Plus during the 3rd quarter valued at approximately $28,000. GAMMA Investing LLC increased its stake in Simulations Plus by 26.0% in the 2nd quarter. GAMMA Investing LLC now owns 2,831 shares of the technology company’s stock worth $52,000 after acquiring an additional 585 shares during the last quarter. Caitong International Asset Management Co. Ltd increased its stake in Simulations Plus by 343.0% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,983 shares of the technology company’s stock worth $73,000 after acquiring an additional 3,084 shares during the last quarter. Finally, Longfellow Investment Management Co. LLC purchased a new stake in shares of Simulations Plus during the 2nd quarter worth approximately $77,000. 78.08% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several brokerages recently weighed in on SLP. William Blair cut shares of Simulations Plus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, June 17th. Weiss Ratings upgraded shares of Simulations Plus from a “sell (d)” rating to a “sell (d+)” rating in a report on Friday, July 10th. Craig Hallum cut shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 target price on the stock. in a research report on Thursday, June 18th. Finally, Wall Street Zen lowered Simulations Plus from a “buy” rating to a “hold” rating in a research report on Saturday, June 13th. Seven equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Simulations Plus has an average rating of “Reduce” and a consensus target price of $17.25.

Read Our Latest Stock Report on Simulations Plus

Insider Activity at Simulations Plus

In related news, Director Walter Woltosz sold 4,177 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $18.44, for a total transaction of $77,023.88. Following the transaction, the director directly owned 3,202,131 shares in the company, valued at approximately $59,047,295.64. This represents a 0.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 19.10% of the company’s stock.

Simulations Plus Price Performance

Shares of SLP opened at $18.43 on Tuesday. The business has a fifty day moving average of $18.33 and a 200 day moving average of $15.67. The company has a market cap of $372.84 million, a PE ratio of 46.07 and a beta of 1.33. Simulations Plus, Inc. has a 52-week low of $11.09 and a 52-week high of $21.01.

Simulations Plus (NASDAQ:SLP – Get Free Report) last posted its quarterly earnings data on Thursday, July 9th. The technology company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.07. Simulations Plus had a net margin of 9.88% and a return on equity of 13.50%. The business had revenue of $21.89 million for the quarter, compared to analysts’ expectations of $20.90 million.

Simulations Plus Profile

(Free Report)

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.

Read More

Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP – Free Report).